Emmaus Medical, Inc. Announces Availability of Endari for Treatment of Sickle Cell Disease

Source :: Plus Company Updates. December 12, 2017
Publication Year :: 2017
Abstract: ATLANTA:Emmaus Life Sciences, Inc. has issued the following news release: Today at the 59th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, Georgia, Emmaus announced availability of [...]

Subjects :: United States. Food and Drug Administration
Glutamine
Drug approval
Sickle cell anemia -- Drug therapy
General interest
News, opinion and commentary
American Society of Hematology
Endari (Medication)

Tools